A Clinical Study of TQB3824 in Subjects With Advanced Cancer

NCT05028218 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: TQB3824 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.